Table 1.
Baseline and demographic characteristics (safety analysis set)
| Parameter | IV cohort (600 mg q24h) n = 10 |
PO cohort (500 mg q24h) n = 11 |
Total N = 21 |
|---|---|---|---|
| Age (years), mean (SD) | 53.1 (13.4) | 50.7 (11.1) | 51.9 (12.0) |
| Gender, n (%) | |||
| Female | 8 (80.0) | 5 (45.5) | 13 (61.9) |
| Male | 2 (20.0) | 6 (54.5) | 8 (38.1) |
| Race, n (%) | |||
| White | 10 (100.0) | 11 (100.0) | 21 (100.0) |
| BMI (kg/m2), mean (SD) | 26.44 (5.73) | 26.24 (5.52) | 26.33 (5.48) |
BMI, body mass index; IV, intravenous; PO, oral; q24h, once a day; SD, standard deviation.